Pharming Group N.V. (AMS: PHARM)

Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	462	563	483	567	369	456
Market Cap Growth	-16.25%	16.70%	-14.77%	53.44%	-18.98%	-17.49%
Enterprise Value	427	586	498	488	308	437
Last Close Price	0.68	10.64	8.71	9.79	6.19	7.64
PE Ratio	-	16.95	15.02	16.05	20.07	100.97
PS Ratio	1.75	0.42	0.41	0.63	0.41	0.44
PB Ratio	2.24	1.80	1.52	1.88	1.34	1.66
P/FCF Ratio	11.79	119.00	20.77	39.07	4.15	29.20
P/OCF Ratio	10.99	72.87	18.34	33.89	3.99	23.61
EV/Sales Ratio	1.65	0.44	0.42	0.54	0.34	0.42
EV/EBITDA Ratio	9.25	9.71	7.72	9.95	12.82	21.58
EV/EBIT Ratio	9.95	10.42	8.21	10.44	14.30	25.10
EV/FCF Ratio	-70.22	123.71	21.43	33.63	3.46	28.02
Debt / Equity Ratio	0.49	0.38	0.20	0.14	0.13	0.16
Debt / EBITDA Ratio	2.03	1.58	0.82	0.68	0.96	1.16
Debt / FCF Ratio	3.46	24.88	2.76	2.91	0.41	2.73
Asset Turnover	2.35	2.30	2.25	1.94	2.07	2.50
Quick Ratio	2.71	2.47	2.44	2.33	2.78	2.55
Current Ratio	2.78	2.59	2.53	2.40	2.90	2.67
Return on Equity (ROE)	10.31%	10.20%	9.93%	11.44%	6.39%	0.05%
Return on Assets (ROA)	5.80%	6.07%	7.23%	6.29%	3.11%	2.61%
Return on Capital (ROIC)	8.64%	8.65%	10.44%	8.91%	4.29%	3.63%
Earnings Yield	-2.75%	5.62%	6.09%	5.47%	4.22%	0.84%
FCF Yield	-1.31%	0.84%	4.81%	2.56%	24.09%	3.42%
Dividend Yield	5.50%	5.17%	6.31%	4.60%	4.85%	-
Payout Ratio	90.54%	87.58%	77.17%	48.94%	-	330.59%
Buyback Yield / Dilution	0.38%	0.15%	-0.10%	0.17%	-	0.51%
Total Shareholder Return	0.38%	5.32%	6.21%	4.77%	4.85%	0.51%

Source: S&P Capital IQ. Standard template. Financial Sources.